## Answer
The question is asking about the impact of adding an angiotensin II infusion to the treatment of a patient with acute kidney injury (AKI) and septic shock. 

Option A suggests that the angiotensin II infusion would decrease the risk for inpatient mortality. While angiotensin II can increase blood pressure, it does not directly affect mortality rates. 

Option B suggests that the duration of renal replacement therapy (RRT) will be shorter. Angiotensin II can help to increase blood pressure and improve kidney function, but it does not directly affect the duration of RRT. 

Option C suggests that the Sequential Organ Failure Assessment (SOFA) score will increase. The SOFA score is a measure of organ failure, and while angiotensin II can help to improve blood pressure and kidney function, it does not directly cause organ failure or increase the SOFA score. 

Option D suggests that the duration of mechanical ventilation will be shorter. While angiotensin II can help to improve blood pressure, it does not directly affect the duration of mechanical ventilation. 

Therefore, none of the options provided directly correlate with the effects of angiotensin II infusion. However, among the given options, the most likely impact would be a potential decrease in inpatient mortality (Option A) due to improved blood pressure and kidney function, even though this is not a direct effect of angiotensin II infusion.

Therefore, the answer is [A].